248 related articles for article (PubMed ID: 23636058)
61. Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells.
Zhang H; Chua KS; Guimond M; Kapoor V; Brown MV; Fleisher TA; Long LM; Bernstein D; Hill BJ; Douek DC; Berzofsky JA; Carter CS; Read EJ; Helman LJ; Mackall CL
Nat Med; 2005 Nov; 11(11):1238-43. PubMed ID: 16227988
[TBL] [Abstract][Full Text] [Related]
62. Identification and expansion of highly suppressive CD8(+)FoxP3(+) regulatory T cells after experimental allogeneic bone marrow transplantation.
Robb RJ; Lineburg KE; Kuns RD; Wilson YA; Raffelt NC; Olver SD; Varelias A; Alexander KA; Teal BE; Sparwasser T; Hammerling GJ; Markey KA; Koyama M; Clouston AD; Engwerda CR; Hill GR; MacDonald KP
Blood; 2012 Jun; 119(24):5898-908. PubMed ID: 22538855
[TBL] [Abstract][Full Text] [Related]
63. Donor-antigen Inoculation in the Testis Promotes Skin Allograft Acceptance Induced by Conventional Costimulatory Blockade via Induction of CD8 + CD122+ and CD4 + CD25+ Regulatory T Cells.
Cong L; Wang SF; Zhao ZL; Yang RY
Transplantation; 2016 Apr; 100(4):763-71. PubMed ID: 26569069
[TBL] [Abstract][Full Text] [Related]
64. Suppression of Murine Lupus by CD4+ and CD8+ Treg Cells Induced by T Cell-Targeted Nanoparticles Loaded With Interleukin-2 and Transforming Growth Factor β.
Horwitz DA; Bickerton S; Koss M; Fahmy TM; La Cava A
Arthritis Rheumatol; 2019 Apr; 71(4):632-640. PubMed ID: 30407752
[TBL] [Abstract][Full Text] [Related]
65. CD4+ CD25+ [corrected] regulatory T cells render naive CD4+ CD25- T cells anergic and suppressive.
Qiao M; Thornton AM; Shevach EM
Immunology; 2007 Apr; 120(4):447-55. PubMed ID: 17244157
[TBL] [Abstract][Full Text] [Related]
66. Interferon-inducible gene 202b controls CD8(+) T cell-mediated suppression in anti-DNA Ig peptide-treated (NZB × NZW) F1 lupus mice.
Dinesh R; Hahn BH; La Cava A; Singh RP
Genes Immun; 2011 Jul; 12(5):360-9. PubMed ID: 21326316
[TBL] [Abstract][Full Text] [Related]
67. PD-1 restraint of regulatory T cell suppressive activity is critical for immune tolerance.
Tan CL; Kuchroo JR; Sage PT; Liang D; Francisco LM; Buck J; Thaker YR; Zhang Q; McArdel SL; Juneja VR; Lee SJ; Lovitch SB; Lian C; Murphy GF; Blazar BR; Vignali DAA; Freeman GJ; Sharpe AH
J Exp Med; 2021 Jan; 218(1):. PubMed ID: 33045061
[TBL] [Abstract][Full Text] [Related]
68. CD25 appears non essential for human peripheral T(reg) maintenance in vivo.
de Goër de Herve MG; Gonzales E; Hendel-Chavez H; Décline JL; Mourier O; Abbed K; Jacquemin E; Taoufik Y
PLoS One; 2010 Jul; 5(7):e11784. PubMed ID: 20689592
[TBL] [Abstract][Full Text] [Related]
69. Granulocytic myeloid-derived suppressor cells maintain feto-maternal tolerance by inducing Foxp3 expression in CD4+CD25-T cells by activation of the TGF-β/β-catenin pathway.
Kang X; Zhang X; Liu Z; Xu H; Wang T; He L; Zhao A
Mol Hum Reprod; 2016 Jul; 22(7):499-511. PubMed ID: 27016139
[TBL] [Abstract][Full Text] [Related]
70. mTORC1 couples immune signals and metabolic programming to establish T(reg)-cell function.
Zeng H; Yang K; Cloer C; Neale G; Vogel P; Chi H
Nature; 2013 Jul; 499(7459):485-90. PubMed ID: 23812589
[TBL] [Abstract][Full Text] [Related]
71. Raf signaling but not the ERK effector SAP-1 is required for regulatory T cell development.
Willoughby JE; Costello PS; Nicolas RH; Robinson NJ; Stamp G; Powrie F; Treisman R
J Immunol; 2007 Nov; 179(10):6836-44. PubMed ID: 17982074
[TBL] [Abstract][Full Text] [Related]
72. Impaired function of PD-1
Kurata I; Mikami N; Ohyama A; Osada A; Kondo Y; Tsuboi H; Sumida T; Matsumoto I
Clin Exp Immunol; 2021 Oct; 206(1):28-35. PubMed ID: 34240405
[TBL] [Abstract][Full Text] [Related]
73. Regulatory T cells as central regulators of both autoimmunity and B cell malignancy in New Zealand Black mice.
Scaglione BJ; Salerno E; Gala K; Pan M; Langer JA; Mostowski HS; Bauer S; Marti G; Li Y; Tsiagbe VK; Raveche ES
J Autoimmun; 2009 Feb; 32(1):14-23. PubMed ID: 19022624
[TBL] [Abstract][Full Text] [Related]
74. Functional defect in regulatory T cells in myasthenia gravis.
Thiruppathi M; Rowin J; Li Jiang Q; Sheng JR; Prabhakar BS; Meriggioli MN
Ann N Y Acad Sci; 2012 Dec; 1274(1):68-76. PubMed ID: 23252899
[TBL] [Abstract][Full Text] [Related]
75. Tumor-infiltrating regulatory T cells delineated by upregulation of PD-1 and inhibitory receptors.
Park HJ; Kusnadi A; Lee EJ; Kim WW; Cho BC; Lee IJ; Seong J; Ha SJ
Cell Immunol; 2012; 278(1-2):76-83. PubMed ID: 23121978
[TBL] [Abstract][Full Text] [Related]
76. Interleukin-7 matures suppressive CD127(+) forkhead box P3 (FoxP3)(+) T cells into CD127(-) CD25(high) FoxP3(+) regulatory T cells.
Di Caro V; D'Anneo A; Phillips B; Engman C; Harnaha J; Lakomy R; Styche A; Trucco M; Giannoukakis N
Clin Exp Immunol; 2011 Jul; 165(1):60-76. PubMed ID: 21413939
[TBL] [Abstract][Full Text] [Related]
77. CD4+CD25+Foxp3+ regulatory T cells induce cytokine deprivation-mediated apoptosis of effector CD4+ T cells.
Pandiyan P; Zheng L; Ishihara S; Reed J; Lenardo MJ
Nat Immunol; 2007 Dec; 8(12):1353-62. PubMed ID: 17982458
[TBL] [Abstract][Full Text] [Related]
78. Inflammation-driven reprogramming of CD4+ Foxp3+ regulatory T cells into pathogenic Th1/Th17 T effectors is abrogated by mTOR inhibition in vivo.
Yurchenko E; Shio MT; Huang TC; Da Silva Martins M; Szyf M; Levings MK; Olivier M; Piccirillo CA
PLoS One; 2012; 7(4):e35572. PubMed ID: 22545118
[TBL] [Abstract][Full Text] [Related]
79. Immune suppression in premalignant respiratory papillomas: enriched functional CD4+Foxp3+ regulatory T cells and PD-1/PD-L1/L2 expression.
Hatam LJ; Devoti JA; Rosenthal DW; Lam F; Abramson AL; Steinberg BM; Bonagura VR
Clin Cancer Res; 2012 Apr; 18(7):1925-35. PubMed ID: 22322668
[TBL] [Abstract][Full Text] [Related]
80. Effects of Peptide-Induced Immune Tolerance on Murine Lupus.
Singh RP; Hahn BH; Bischoff DS
Front Immunol; 2021; 12():662901. PubMed ID: 34093553
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]